Navigation Links
Cynosure Announces Schedule of Upcoming Investor Conferences

WESTFORD, Mass., June 3 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that President and Chief Executive Officer Michael Davin and Chief Financial Officer Timothy Baker will discuss the company's business outlook, growth strategy and recent financial results at the following investor conferences this month:

-- On Thursday, June 12, the company will present at the 7th Annual

Needham & Company Biotechnology and Medical Technology Conference in

New York City. The presentation is scheduled to begin at 10:00 a.m.


-- On Wednesday, June 25, Cynosure will present at the Jefferies 2nd

Annual Healthcare Conference in New York City. The presentation is

scheduled to begin at 3:45 p.m. ET.

Investors interested in listening to the live webcasts of these presentations should log on to the "Investor Relations" section of Cynosure's website,, and click on the link labeled "Events." The presentations also will be archived on the company's website.

About Cynosure, Inc.

Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular lesions, rejuvenate skin through the treatment of shallow vascular and pigmented lesions, laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit

SOURCE Cynosure, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cynosure Appoints H. Travis Lee as Vice President of Global Marketing
2. Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth
3. Cynosure Introduces Smartlipo MPX(TM) Dual Wavelength Workstation for LaserBodySculpting(SM)
4. Cynosure Announces Upcoming Investor Presentations at Cowen and Citi Investor Conferences
5. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
6. Cynosure to Announce Fourth-Quarter and Full Year 2007 Financial Results on February 12
7. Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference
8. Boston Scientific Announces CEO Jim Tobin to Extend Tenure
9. Growing Generations Announces Surrogacy Program for Men with HIV
10. DRCs Metrigraphics Announces Family of Micro-Induction Coils for Implanted and Traditional Medical Applications
11. Ingenuity Systems Announces Multi-Year Agreement With Boehringer Ingelheim
Post Your Comments:
(Date:11/25/2015)... 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced  today ... rights plan (Rights Plan) in an effort to preserve ... under Section 382 of the Internal Revenue Code (Code). ... use of its NOLs could be substantially limited if ... Section 382 of the Code. In general, an ownership ...
(Date:11/25/2015)... 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... CEO of Neurocrine Biosciences, will be presenting at the ... New York . .   ... 5 minutes prior to the presentation to download or ... will be available on the website approximately one hour ...
(Date:11/25/2015)... 2015 The Global Genomics ... professional and in-depth study on the current state ... ) , The report ... definitions, classifications, applications and industry chain structure. The ... markets including development trends, competitive landscape analysis, and ...
(Date:11/24/2015)... Calif. , Nov. 24, 2015 Cepheid ... will be speaking at the following conference, and invited ... New York, NY      Tuesday, December 1, 2015 ... New York, NY      Tuesday, December 1, 2015 ... Jaffray Healthcare Conference, New York, NY ...
Breaking Biology Technology:
(Date:11/19/2015)... , Nov. 19, 2015  Although some 350 companies ... dominated by a few companies, according to Kalorama Information. These ... 51% of the market share of the 6.1 billion-dollar ... The World Market for Molecular Diagnostic s .    ... market is still controlled by one company and only ...
(Date:11/18/2015)... ALBANY, New York , November 18, 2015 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2021. According to ... bn in 2014 and is anticipated to reach US$29.1 ... 2015 to 2021. North America ...
(Date:11/17/2015)... , November 17, 2015 ... 19 novembre  2015.  --> Paris , ... --> DERMALOG, le leader de l,innovation biométrique, a ... fois passeports et empreintes sur la même surface de ... passeports et l,autre pour les empreintes digitales. Désormais, un ...
Breaking Biology News(10 mins):